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Trinucleotide repeat expansions are the genetic cause of numerous human diseases, including fragile X mental
retardation, Huntington disease, and myotonic dystrophy type 1. Disease severity and age of onset are critically linked
to expansion size. Previous mouse models of repeat instability have not recreated large intergenerational expansions
(‘‘big jumps’’), observed when the repeat is transmitted from one generation to the next, and have never attained the
very large tract lengths possible in humans. Here, we describe dramatic intergenerational CTG CAG repeat expansions
of several hundred repeats in a transgenic mouse model of myotonic dystrophy type 1, resulting in increasingly severe
phenotypic and molecular abnormalities. Homozygous mice carrying over 700 trinucleotide repeats on both alleles
display severely reduced body size and splicing abnormalities, notably in the central nervous system. Our findings
demonstrate that large intergenerational trinucleotide repeat expansions can be recreated in mice, and endorse the
use of transgenic mouse models to refine our understanding of triplet repeat expansion and the resulting
pathogenesis.
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Introduction
Trinucleotide DNA repeat expansion is the mutational
cause of at least 14 neurological, neurodegenerative, and
neuromuscular diseases in humans, including Huntington
disease, many spinocerebellar ataxias, fragile X syndrome,
and myotonic dystrophy type 1 (DM1). While expansion of
other repeats can also be pathological, the majority of the
triplet diseases are linked to instability of CTG CAG repeat
sequences [1,2]. The size of the inherited expansion is
critically linked to the severity of the disease and the age of
onset. The most surprising feature of this peculiar type of
mutation is the marked tendency of the expanded repeat to
further increase in size from one generation to the next,
resulting in increased severity of the symptoms and earlier
age of onset (anticipation) [3,4]. Anticipation is particularly
evident in DM1 and is explained by the dramatic inter-
generational instability of the CTG trinucleotide repeat: very
large intergenerational expansions (‘‘big jumps’’) of several
hundred repeats are frequently observed in DM1 families [5].
The repeat, normally ranging between 5–37 CTG, is expanded
in DM1 patients, reaching up to 4,000 CTG in the most severe
congenital form of the disease [6]. In addition, the disease-
associated repeat expansion is also unstable in somatic tissues
throughout the lifetime of the individual [7,8].
Modeling trinucleotide repeat instability in transgenic
mice has been a challenge for more than a decade. Transgenic
mice have been generated to provide in vivo models to study
repeat instability in the germline and during somatic
development, as well as to provide models of disease
pathogenesis. Initial attempts using cDNA transgenes con-
taining expanded CAG CTG repeats failed to recreate repeat
dynamics. A second generation of mice, carrying longer
CAG CTG tracts, or moderately sized expansions within their
native genomic DNA context, reproduced intergenerational
and somatic instability [9]. However, large intergenerational
length increments of several hundred repeats have never
been observed in these animals (Figure 1A). The smaller
magnitude of intergenerational expansions in transgenic
models raised the question of the adequacy of mice to fully
model trinucleotide repeat instability.
We report, to our knowledge for the ﬁrst time, the
occurrence in a transgenic mouse model of DM1 of CTG
trinucleotide repeat big jumps in association with a strong
phenotype and molecular abnormalities. This work demon-
strates that large intergenerational mutations can accumulate
in a mouse model, and provides a unique tool to further
improve our understanding of the metabolism of unstable
trinucleotide repeats associated with human disease.
Results/Discussion
We have previously generated the DM300–328 transgenic
mouse line, which carries over 300 CTG repeats embedded in
45 kb of human genomic sequence from the DM1 locus. This
line displays the highest frequency of intergenerational
instability in mice reported until now (;90% expansions in
the offspring). Nevertheless, repeat changes never reached
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maternal and paternal transmissions, respectively [10].
Recently, two different mice derived from the DM300–328
line, carrying 430 and 460 CTG (male and female, respec-
tively), transmitted big jumps ofþ250 CTG andþ480 CTG in a
single generation, producing offspring with 680 CTG and 940
CTG (Figure 1A and 1B). The male, carrying a remarkably
long 680-CTG tract, transmitted larger expansions to 82% of
its offspring (11% of transmissions resulted in repeat
contraction). Among expansions, 11% consisted of further
big jumps with a mean repeat gain of þ290 CTG. We derived
mouse sub-lines called ‘‘XL’’ for mice carrying ;600–700
CTG and ‘‘XXL’’ for mice carrying ;900-1000 CTG. Further
large size gains were observed in these lines, and a male
carrying 1,230 CTG was obtained, resulting from an addi-
tional þ270-CTG expansion. Very large increments of CTG
repeats seem to arise more frequently through male than
female transmissions, with an overall frequency of 5% (Figure
1C).
We have previously shown that mice carrying 350–500 CTG
display a mild phenotype, consistent with a trans-dominant
effect of toxic RNA transcripts carrying CUG expansions [11–
13]. A phenotype was only detected in homozygous mice for
the low expressing transgene, suggesting a dose effect of the
mutant RNA. Hemizygous mice for the very large expansions
of 900 to 1,230 CTG did not show an obvious phenotype,
indicating that the dramatic increase in CTG repeat size is
not sufﬁcient to overcome the low expression of the mutant
RNA. However, homozygous mice carrying 700 CTG on one
allele and 900 or 1,230 CTG on the other displayed a severe
phenotype with very high mortality; 60% animals died before
seven months of age. These animals exhibited severe growth
retardation from birth (Figure 2) and marked splicing
abnormalities in the central nervous system and muscle,
through expression of toxic CUG-containing expanded
myotonic dystrophy protein kinase (DMPK) transcripts
(Figure 3). Notably, abnormal splicing of glutamate receptor,
ionotropic, N-methyl D-aspartate 1 (Grin1/Nmdar1) and
microtubule-associated protein tau (Mapt/Tau) transcripts
was detected in the brain of homozygous transgenic mice
carrying .700 CTG trinucleotide repeats within their human
genomic context. In addition, a change in the distribution of
muscleblind-like (Mbnl1 and Mbnl2) isoforms either carrying
or not carrying exon 7 was observed in the brain of these
mice (Figure 3). To our knowledge, this is the ﬁrst report of
RNA splicing abnormalities in the central nervous system of a
mouse model of DM1. The insulin receptor (Insr) and chloride
channel 1 (Clcn1) transcripts also showed abnormal splicing
patterns in skeletal muscle of the same animals (Figure 3).
In summary, we report remarkable, very large intergenera-
tional changes in CTG repeat length in a mouse model of
DM1. Striking expansions of several hundred repeats in a
Figure 1. Big Jumps in Mice: Striking Intergenerational Trinucleotide
Repeat Instability in Transgenic Mice
(A) Transgenic mouse models of CAG CTG instability previously
generated exhibited modest intergenerational repeat expansions (blue
dots). The largest expansions reported were smaller than 10 CAG CTG
repeats, with the exception of the DM300–328 line, in which inter-
generational repeat gains reached þ60 CTG [9]. Large CTG big jumps of
several hundred repeats were recreated in a transgenic mouse model of
DM1 carrying over 400 CTG repeats (red dots). To our knowledge, the
repeat gains observed are the largest ever reported in transgenic models
of unstable trinucleotide repeats.
(B) Transmission of a very large expansion from a male parent (P) to its
offspring. m1 and m2 indicate 100-bp and 250-bp molecular weight
markers, respectively.
(C) Intergenerational CTG size variation (yy axis) is represented for
different CTG repeat lengths (xx axis) in male (top graph, blue dots) and
female transmissions (bottom graph, red dots).
doi:10.1371/journal.pgen.0030052.g001
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Author Summary
Many neurological and/or neuromuscular diseases, such as myo-
tonic dystrophy, Huntington disease, and fragile X mental retarda-
tion are caused by an increase in the size of a repeated DNA
sequence within a specific gene. These repetitive DNA sequences
are prone to expansion, increasing in size when transmitted from
one generation to the next, which results in more severe symptoms
and earlier age of onset. In myotonic dystrophy, the DNA repeat can
undergo very large increments of several hundred units (frequently
called ‘‘big jumps’’), usually associated with the most severe clinical
picture. Until now, big jumps have not been observed in mice
carrying the disease mutation, leading to questions about the
adequacy of mice to fully model DNA repeat instability. We now
report that these large increments in the size of DNA repeats can
occur in transgenic mice, resulting in animals that carry extremely
large repeated sequences. These mice are remarkably small and
display abnormalities in the metabolism of multiple messenger
RNAs, notably in brain and muscle. Our findings strongly support
the use of transgenic mice to resolve the complex dynamics of
simple repetitive DNA sequences associated with human inherited
diseases, and to investigate the molecular events that underlie the
development of disease symptoms.single generation resulted in the XL and XXL mouse lines,
which carry the largest expansion ever observed in mice and
display severe phenotypic and molecular abnormalities when
homozygous for the very large repeat tract. The ﬁrst two very
large expansions arose in the same line but in mice raised in
different animal facilities. The occurrence of these events in
the line that we have the most extensively studied, is probably
associated with a higher probability of getting very large
expansions when the size of the repeat in the transmitting
parent is larger, as Figure 1A appears to suggest. However,
further mouse breeding strategies, especially with DNA
repair–deﬁcient lines, are needed to decipher the mecha-
n i s m si n v o l v e di nt h ef o r m a t i o no ft h e s ev e r yl a r g e
expansions. The observation that hemizygous mice carrying
very large repeats (over 1,000 CTG) do not display an obvious
phenotype suggests that the expanded RNA dose is not
sufﬁcient to induce signiﬁcant abnormalities. It is possible
that the expression of the DMPK transgene might be lowered
by the expanded CTG repeat, although this has not been
described in DM1 patients. Furthermore, we cannot exclude a
heterochromatinization spreading effect of the large repeat
on the transgene and/or on the adjacent mouse genomic
sequences. If only revealed by homozygous animals, this effect
could contribute, at least partially, to the phenotype of mice
carrying two very large CTG repeats. Future experiments will
address these possibilities. Nevertheless, our results directly
challenge the assumption that dramatic intergenerational
triplet repeat expansions cannot be recreated in mouse
models of unstable DNA. This important proof of principle
provides an experimental foundation to further reﬁne our
understanding of the metabolism of disease-associated
trinucleotide repeats. The lines generated in our study afford
a unique tool to explore the complex dynamics of simple
trinucleotide repeats, the increasing phenotypic severity
Figure 3. Abnormal RNA Splicing in Homozygous Mice Carrying over 600
CTG Trinucleotide Repeats on Both Alleles
(A) Splicing abnormalities in the central nervous system. Abnormal
splicing patterns were detected in the frontal cortex of 4-wk-old
homozygous female mice (n ¼ 3), when compared to wild-type (n ¼ 3)
and hemizygous female controls (n ¼ 2) for mRNA transcripts of Grin1
(favored exon 21 skipping), Mapt (altered splicing patterns of exons 2
and 3, and favored exon 10 skipping), Mbnl1 (favored exon 7 inclusion),
and Mbnl2 (favored exon 7 inclusion). Splicing abnormalities were also
observed in the hippocampus and striatum (unpublished data).
(B) Splicing abnormalities in skeletal muscle. Reverse transcription-PCR
experiments showed mRNA splicing defects for Insr (favored exon 11
inclusion) and Clcn1 (modification in the ratio and quantity of þ/– exon
7a isoforms) in the gastrocnemius muscle of 4-wk-old homozygous
female mice (n¼2) when compared to wild-type (n¼3) and hemizygous
female controls (n ¼ 1).
m, DNA molecular weight marker; wt, wild-type; XL, 600–700 CTG; XXL,
900-1000 CTG; SXXL, .1200 CTG.
doi:10.1371/journal.pgen.0030052.g003
Figure 2. Body Size Reduction in Homozygous Mice Carrying Very Large
CTG Repeat Expansions on Both Alleles
Marked growth retardation in a 4-wk-old homozygous mouse carrying
;1,230 and ;700 CTG repeats compared to a control littermate.
doi:10.1371/journal.pgen.0030052.g002
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Very Large Triplet Repeat Expansions in DM1 Micethrough generations, as well as the molecular bases of RNA
toxicity in disease pathogenesis.
Materials and Methods
Transgenic mice. The transgenic mice used in this study carried 45
kb of human genomic DNA cloned from a DM1 patient as described
by Seznec et al.[10]. Animals were bred onto a mixed background
(C57BL6/129/OLA/FVB). Transgenic status was assayed by PCR using
DMHR4 and DMHR5 oligonucleotide primers [10]. Tail DNA was
ampliﬁed by PCR with oligonucleotide primers 101 and 102, and CTG
repeat size was determined after electrophoresis of ampliﬁcation
products through a 4% polyacrylamide denaturing gel [10]. For the
very large expansions ( 700 CTG), repeat size was measured after
resolving the ampliﬁcation products on a large 0.7% (w/v) agarose gel
(20 3 35 cm). Animal care was performed according to institutional
guidelines and approved by the Police Prefecture of Paris.
RT-PCR analysis of alternative splicing. Total RNA was extracted
from microdissected brain regions using the RNeasy Mini Kit (Qiagen,
http://www.qiagen.com). cDNA synthesis was primed with random
hexamers. cDNA samples were treated with RNase A at 37 8C for 20
min.MostPCRampliﬁcationswerecarriedoutfor21–26cycles,within
the linear range of ampliﬁcation for each gene. The PCR ampliﬁ-
cationforMaptexon10alternativesplicinganalysiswasperformedfor
28 cycles, given the low abundance of the isoform lacking exon 10. The
following oligonucleotide primers were used: Grin1, 59-
ATGCCCCTGCCACCCTCACTTTTG-39 and 59-
GCAGCTGGCCCTCCTCCCTCTCA-39; Mapt exons 2 and 3, 59-
ACTCTGCTCCAAGACCAAG-39 and 59-
TGTCTCCGATGCCTGCTTC-39; Mapt exon 10, 59-CAC-
CAAAATCCGGAGAACGA-39 and 59-CTATTTGCACCTTGC-
CACCT-39; Mbnl1 exon 7, 59-GCTGCCCAATACCAGGTCAAC-39 and
59-TGGTGGGAGAAATGCTGTATGC-39; Mbnl2 exon 7, 59-AC-
CGTAACCGTTTGTATGGATTAC-39 and 59-CTTTGGTAAGGGAT-
GAAGAGCAC-39; Insr exon 11, 59-GAGGATTACCTGCACAACG-39
and 59-CACAATGGTAGAGGAGACG-39; Clcn1 exon 7a, 59-
CTTTGTAGCCAAGGTG-39 and 59-ACGGAACACAAAGGCACTGA-
39; and TATA box binding protein (Tbp), 59-GGTGTGCACAGGAGC-
CAAGAGTG-39 and 59-AGCTACTGAACTGCTGGTGGGTC-39. PCR
products were resolved through 2.5% (w/v) agarose gels and stained
with ethidium bromide.
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